Answer
For Ursofalk 250 mg/5 ml ursodeoxycholic acid suspension in children aged 1 month to 18 years with cystic fibrosis weighing under 10 kg, use a commercially available single-use 2 ml graduated syringe, which is not provided in the pack.
Sources for this answer
- Ursofalk 250mg/5ml SuspensionDr. Falk Pharma UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 10Document updated
Sources checked